A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that a 2019 Medicare opioid safety ...

A new study led by researchers at the Harvard Pilgrim Health Care Institute found that a 2019 Medicare opioid safety policy ...

The authors add, "Pregnancy hypertension outcome prediction models were designed and validated for initial assessment of risks for mothers; this study shows that such 'static' models, if used ...

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data from Part B of the DeFianCe study ...

Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ...

A new study from the University of Suffolk is set to explore motor neurone disease (MND) and how it affects couples.

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

Discover how your mind filters out distractions. New research reveals the specialized neural mechanisms that actively block ...